Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is FAST-Forward/ultra-hypofractionation suitable for an early-stage breast patient after a lumpectomy with oncoplastic reduction?
Answer from: Radiation Oncologist at Community Practice
Yes, FAST-Forward is fine after oncoplastic reduction as long as dose homogeneity criteria can be met (V105 < 5%).
Comments
Radiation Oncologist at Indiana University Health
@Sushil Beriwal, is there any thought that if a pa...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
As long as dosimetric and clinical criteria are me...
15540
15544
Sign In
or
Register
to read more
26566
Related Questions
Does a post-surgical hematoma in the breast affect your recommendations for partial breast RT?
Is it appropriate to consider ultra-hypofractionation for phyllodes tumors of the breast when adjuvant radiotherapy is indicated?
Would you consider whole breast re-irradiation in a patient with a second/recurrent breast cancer and prior history of breast radiation therapy many years ago, if the tumor characteristics are not amenable to partial breast re-irradiation?
How would you manage a pT2N1a invasive ductal carcinoma s/p lumpectomy and sentinel lymph node biopsy with ECE, and two mildly avid axillary lymph nodes on post-op PET/CT?
What is your preferred comprehensive nodal irradiation approach in non-metastatic breast cancer patients with underlying respiratory diseases or poor baseline respiratory function in light of the findings from the RadComp Trial?
Would you offer prone APBI with IMRT/VMAT?
How does SUPREMO alter your recommendations for PMRT?
How would you approach reirradiation in a patient with a history of whole-breast RT many years ago, now with a small intermediate-grade DCIS s/p lumpectomy with an elevated DCISionRT?
How do you manage a symptomatic primary breast tumor in a patient with metastatic disease?
Does a high genomic risk score impact your radiation fields for patients with breast cancer?
@Sushil Beriwal, is there any thought that if a pa...
As long as dosimetric and clinical criteria are me...